Verified

AMS Henry Burger Postdoctoral Research Award

Australasian Menopause Society

Conditions

• The award is for one year and is valued at $50,000. Funds can be used at the awardee's discretion for either salary support or research expenses.

• Awardee must attend the AMS Annual Congress in the year following tenure and present their current research progress and findings. A final report is required by March of the following year.

• Research must be in the field of menopausal medicine.

Applications must include:

• A project plan (max 3 pages, excluding references), including title, institution, hypothesis, aims, methods, expected outcomes, and an itemised budget.

• A short CV (max 3 pages) referring to the last 5 years only (adjusted for career interruption).

• Career disruption, if relevant (max 1 page).

• Copy of academic transcript detailing date of PhD completion.

• One referee report (approx. 1 page). The referee must be external to the proposed project's institution and cannot be a co-investigator.

• Letter from the Head of the Department indicating the availability of suitable facilities and scientific support.

Selection Applications are assessed by a Selection Committee based on:

• Project proposal (scientific quality and relevance to the field of menopause)- 50% weighting.

• Track record (publications, abstracts, awards/achievements) - 40% weighting.

• Referee and head of department reports - 10% weighting.

Administration and publications

• The award recipient must be undertaking work within an approved institution. Financial administration will be through the institution's finance office.

• Any publications derived from the project must acknowledge the financial support of the Australasian Menopause Society

AI Based Application Success Predictor

1. Direct Relevance to Menopause Research (Strongest Predictor)

AMS is dedicated to advancing knowledge of:

Menopause
Perimenopause
Healthy ageing
Midlife women's health
Menopausal hormone therapy
Long-term health consequences of menopause

Projects directly addressing these areas are most competitive.

2. Original Research Excellence

For AMS scientific awards, the society specifically requires:

Original research
Peer-reviewed scientific work
New data and findings

Review articles and opinion pieces are generally less competitive than original investigations.

3. Clinical Impact

AMS places substantial emphasis on research that improves:

Menopause management
Symptom treatment
Women's quality of life
Long-term health outcomes
Evidence-based clinical decision-making

Projects with clear clinical implications tend to score highly.

4. Novelty of Findings

Published AMS judging criteria specifically evaluate:

Novelty of data
Original findings
Contribution to knowledge

Research offering new insights into menopause-related conditions is particularly attractive.

5. Strong Methodology and Statistical Power

AMS award criteria explicitly include assessment of:

Research methods
Statistical power
Study design quality

Competitive applications typically demonstrate rigorous methodology and appropriately powered analyses.

6. Translation Into Clinical Care

One of AMS's formal scoring criteria is the extent to which findings can be translated into patient care.

Successful projects often demonstrate:

Practice-changing potential
Clinical applicability
Improved patient outcomes
Better menopause management strategies

This is a distinctive and important review factor.

7. Investigator Contribution

AMS specifically evaluates the applicant's role in:

Data collection
Study design
Methodological development
Manuscript preparation

Applicants demonstrating major intellectual and scientific contributions tend to be more competitive.

8. Support for Early-Career Researchers

AMS offers:

Jean Hailes Memorial Prize
Student scholarships
Travel grants
Early-career presentation awards

These programs indicate a strong commitment to developing future menopause researchers.

9. Publication Quality

Successful research outputs are generally expected to:

Appear in peer-reviewed journals
Meet high scientific standards
Contribute significantly to menopause literature

Publication quality is a formal criterion in AMS scientific publication awards.

10. Alignment with Current AMS Priorities

Topics currently emphasized by AMS include:

Menopause management
Hormone therapy
Healthy ageing
Midlife women's health
Diverse menopause experiences
Education and healthcare delivery
Rural and underserved populations

Projects addressing these contemporary priorities may have an advantage.

Frequently Successful Research Themes

Historically competitive AMS research areas include:

Menopausal hormone therapy (MHT/HRT)
Vasomotor symptoms
Genitourinary syndrome of menopause
Osteoporosis and bone health
Cardiovascular health after menopause
Premature ovarian insufficiency
Healthy ageing
Mental health during menopause
Quality-of-life outcomes
Models of menopause care
Health equity in menopause services
Menopause education and implementation science

Funding Strategy

A highly competitive AMS application typically includes:

A research question directly related to menopause or midlife women's health.
Original and innovative scientific findings.
Strong methodology and statistical rigor.
Clear relevance to clinical practice.
Demonstrated investigator leadership and contribution.
Potential to improve patient outcomes.
Publication and dissemination plans through high-quality scientific channels.

Key Insight

Compared with many broader women's health funders, AMS places particularly strong emphasis on clinical translation, menopause-specific relevance, originality of research, and direct impact on the care of women during midlife and menopause. Projects that combine scientific rigor with clear benefits for menopause management and healthy ageing appear to have the highest likelihood of success.

Specialties

Gynecology

Eligibility Requirements

• Applicants must be financial members of the AMS.

• Be less than 10 years since graduating from a PhD, allowing for career disruption, and have this conferred before the year of the award.

• Payments will only be made once ethics approval is obtained and study commencement has been confirmed.

• The research must be undertaken predominantly in Australia or New Zealand.

• Applicants can only receive this award once.

Eligible Countries:

Australia

New Zealand

Sponsor Details

Sponsor Institute/Organizations: Australasian Menopause Society

Sponsor Type: Corporate/Non-Profit

Address: 50 Carrington St, Pascoe Vale South VIC 3044

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity